A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate how the body absorbs and removes LY2605541,
insulin lispro, and a mixture of both from the blood. The study has two parts. Participants
may enroll in only one part. Each part has four treatment periods in a fixed order. The study
will last approximately 8 weeks, not including screening. Screening is required within 28
days prior to the start of the study.